Tuberculosis in UK prisoners: a challenge for control

Anderson, Charlotte; Story, Alistair; Brown, Tim; Drobniewski, Francis; Abubakar, Ibrahim
April 2010
Journal of Epidemiology & Community Health;Apr2010, Vol. 64 Issue 4, p18
Academic Journal
Aims Prisoners include a disproportionate number of those with social and clinical risk factors for tuberculosis and pose a challenge for control. The aim of this study was to investigate the characteristics of prisoners with tuberculosis in order to inform clinical management and control policy. Methods Between 2004 and 2007, 205 patients newly diagnosed as having tuberculosis in prison in the UK identified in national surveillance reports were studied. Isolates from prisoners were tested for susceptibility to first-line antituberculosis drugs and strain typed where possible. Results Prisoners were significantly more likely to be UK-born (47 vs 25%), to be white (33 vs 22%) and to have pulmonary disease (75 vs 56%) than other tuberculosis patients. Pulmonary cases were also more likely to be sputum-smear-positive (69 vs 57%). Over one-third of culture confirmed cases among prisoners were resistant to isoniazid. Less than half (48%) of patients diagnosed as having tuberculosis in prison completed treatment, with a fifth lost to follow-up. Discussion In the UK, imprisonment is an important risk factor for tuberculosis, especially drug-resistant and infectious forms of the disease. The management of tuberculosis among UK prisoners is further complicated by high rates of loss to follow-up care and poor treatment outcomes.


Related Articles

  • Government told to set clearer TB action targets.  // Nursing Standard;2/9/2005, Vol. 19 Issue 22, p6 

    Focuses on specific targets needed to ensure the British government's action plan on tuberculosis (TB). Reason for the limitation of the plan; Scope of the action plan; Importance of controlling the spread of the disease.

  • BCG vaccine.  // Reactions Weekly;3/28/2009, Issue 1245, p8 

    The article describes several cases of human immunodeficiency virus (HIV)-positive infants who developed Bacillus Calmette-Guérin (BCG) infections after receiving a BCG vaccine. One of the patients, an 11-month-old infant, had enlarged, matted axillary lymph nodes, pneumonia, oral candidiasis...

  • Management of Spontaneous Pneumothorax in a Developing Caribbean Nation: A Clinical Practice Audit. Cawich, Shamir O.; Williams, Eric W.; Irvine, Roger; Harding, Hyacinth E.; Isaacs, Melody // Internet Journal of Pulmonary Medicine;2009, Vol. 10 Issue 2, p8 

    A five year clinical audit was conducted between January 1, 2000 and January 1, 2005 to evaluate the management of patients with spontaneous pneumothoraces at three tertiary referral centres across Kingston, the capital city of Jamaica. Secondary pneumothoraces (SSP) were considered present if...

  • Another Step Down the Development Pipeline for the Novel Tuberculosis Vaccine MVA-85A. Dockrell, Hazel M. // Journal of Infectious Diseases;6/15/2011, Vol. 203 Issue 12, p1708 

    In this article the author discusses development of the novel tuberculosis vaccine MVA-85A. The author says that infants had lower enzyme-linked immunosorbent spot (ELISPOT) responses to MVA85A than children aged 2-5 years, adolescents, or adults. The author further says that there were several...

  • Focus: Tuberculosis. Onyebujoh, Phillip; Rook, Graham A. W. // Nature Reviews Microbiology;Dec2004, Vol. 2 Issue 12, p930 

    The article provides information about tuberculosis including its recent worldwide developments. Recent study reveals that one-third of the world's population is infected with Mycobacterium tuberculosis. Recently, the genomes of two M. tuberculosis' strains have been sequenced to identify its...

  • DNA vaccine for TB prevents recurrence. Bowden, Rachel // GP: General Practitioner;2/11/2005, p4 

    This article informs that a DNA vaccine for TB prevents recurrence of the disease in mice. Researchers infected four groups of mice with a low dose of Mycobacterium tuberculosis and treated them with the anti-tubercular agents isoniazid and pyrazinamide five times in the first four to 16 weeks...

  • Progression to Active Tuberculosis, but Not Transmission, Varies by Mycobacterium tuberculosis Lineage in The Gambia. de Jong, Bouke C.; Hill, Philip C.; Aiken, Alex; Awine, Timothy; Antonio, Martin; Adetifa, Ifedayo M.; Jackson-Sillah, Dolly J.; Fox, Annette; DeRiemer, Kathryn; Gagneux, Sebastien; Borgdorff, Martien W.; McAdam, Keith P. W. J.; Corrah, Tumani; Small, Peter M.; Adegbola, Richard A. // Journal of Infectious Diseases;10/1/2008, Vol. 198 Issue 7, p1037 

    Background. There is considerable variability in the outcome of Mycobacterium tuberculosis infection. We hypothesized that Mycobacterium africanum was less likely than M. tuberculosis to transmit and progress to tuberculosis disease. Methods. In a cohort study of patients with tuberculosis and...

  • Characterization of Mycobacterium tuberculosis Central Asian Strain1 using mycobacterial interspersed repetitive unit genotyping. Ali, Asho; Hasan, Zahra; Tanveer, Mahnaz; Siddiqui, Amna R.; Ghebremichael, Solomon; Kallenius, Gunilla; Hasan, Rumina // BMC Microbiology;2007, Vol. 7, p1 

    Background: The Central Asian Strain1 (CAS1) genogroup of Mycobacterium tuberculosis (MTB) is the most prevalent in Pakistan, India and Bangladesh. Mycobacterial interspersed repetitive units variable number tandem repeat (MIRU-VNTR) typing is a reliable and reproducible method for...

  • What is TB disease?  // Tuberculosis: Getting Healthy, Staying Healthy;Jun2008, Issue 8, p9 

    The article provides an answer to a question of what is the nature of the tuberculosis (TB) disease.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics